ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
Martina Kočan(Discovery Institute), Mohammed Akhter Hossain(Florey Institute of Neuroscience and Mental Health), Dana S. Hutchinson(Protein Express (United States)), Chrishan S. Samuel(Discovery Institute), Alexander I. Agoulnik(Florida International University), Sheng Yu Ang(Monash University), Juan Marugán(National Institutes of Health), Ross A. D. Bathgate(The University of Melbourne), Chao Wang(Monash University), Jingbo Xiao(National Center for Advancing Translational Sciences), Mohsin Sarwar(Monash University)
Cited by 62
Related Papers
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse
|Nature Genetics|2000|351
Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene
|American Journal Of Pathology|2001|279